MWP
DCPH

Meridian Wealth Partners’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Meridian Wealth Partners’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14
Closed -$1K – 1362
2021
Q1 		$1K Buy
+14
New +$652 ﹤0.01% 1284

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Meridian Wealth Partners's DCPH Position: Q2 2021 in Review

Meridian Wealth Partners sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2021, closing a stake of 14 shares — an estimated $1K sold.

Meridian Wealth Partners first reported a position in DCPH in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 147 funds tracked by Wall St. Rank hold DCPH as of Q2 2021.

  • Meridian Wealth Partners reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Meridian Wealth Partners sold 14 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $1K.
  • Meridian Wealth Partners first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Meridian Wealth Partners's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1K in Q1 2021.
  • 147 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Meridian Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.